Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents.

Madrigal-Burgaleta R, Bernal-Rubio L, Berges-Gimeno MP, Carpio-Escalona LV, Gehlhaar P, Alvarez-Cuesta E.

J Allergy Clin Immunol Pract. 2018 Aug 8. pii: S2213-2198(18)30468-9. doi: 10.1016/j.jaip.2018.07.031. [Epub ahead of print]

PMID:
30098410
2.

[Successful oral desensitization to levothyroxine. Report of one case].

Guzmán MA, Sepúlveda C, Liberman C, Cornejo R, Roizen G, Cereceda D, Lara MF, Álvarez-Cuesta E.

Rev Med Chil. 2018 Mar;146(3):394-398. doi: 10.4067/s0034-98872018000300394. Spanish.

3.

Assessment of Antihistamines and Corticosteroids as Premedication in Rapid Drug Desensitization to Paclitaxel: Outcomes in 155 Procedures.

Lopez-Gonzalez P, Madrigal-Burgaleta R, Carpio-Escalona LV, Bernal-Rubio L, Guerra E, Berges-Gimeno MP, Alvarez-Cuesta E.

J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1356-1362. doi: 10.1016/j.jaip.2017.11.013. Epub 2017 Dec 13.

PMID:
29248386
4.

Chemotherapy in Mastocytosis: Administration Issues, Hypersensitivity, and Rapid Drug Desensitization.

Solano-Solares E, Madrigal-Burgaleta R, Carpio-Escalona LV, Bernal-Rubio L, Berges-Gimeno MP, Alvarez-Cuesta E.

J Investig Allergol Clin Immunol. 2017;27(5):315-317. doi: 10.18176/jiaci.0171. No abstract available.

5.

A Phase I clinical trial with subcutaneous immunotherapy vaccine of Timothy grass pollen extract according to EMA guidelines.

Sola J, Sánchez V, Landeta A, Madariaga B, Martínez A, Álvarez-Cuesta E.

Immunotherapy. 2015;7(4):343-52. doi: 10.2217/imt.15.8.

PMID:
25917626
6.

Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization.

Alvarez-Cuesta E, Madrigal-Burgaleta R, Angel-Pereira D, Ureña-Tavera A, Zamora-Verduga M, Lopez-Gonzalez P, Berges-Gimeno MP.

Allergy. 2015 Jul;70(7):784-94. doi: 10.1111/all.12620. Epub 2015 Apr 24.

PMID:
25832325
7.

Hypersensitivity reactions to racemic calcium folinate (leucovorin) during FOLFOX and FOLFIRI chemotherapy administrations.

Ureña-Tavera A, Zamora-Verduga M, Madrigal-Burgaleta R, Angel-Pereira D, Berges-Gimeno MP, Alvarez-Cuesta E.

J Allergy Clin Immunol. 2015 Apr;135(4):1066-7. doi: 10.1016/j.jaci.2014.09.045. Epub 2014 Nov 7. No abstract available.

PMID:
25457996
8.

Successful rapid desensitization to methylprednisolone sodium hemisuccinate: a case report.

Angel-Pereira D, Berges-Gimeno MP, Madrigal-Burgaleta R, Ureña-Tavera MA, Zamora-Verduga M, Alvarez-Cuesta E.

J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):346-8. doi: 10.1016/j.jaip.2013.12.011. Epub 2014 Apr 2. No abstract available.

PMID:
24811029
9.

Rapid desensitization to chemotherapy and monoclonal antibodies is effective and safe. Reply.

Alvarez-Cuesta E, Madrigal-Burgaleta R, Berges-Gimeno MP, Angel-Pereira D.

Allergy. 2013 Nov;68(11):1483-4. No abstract available.

PMID:
24498642
10.

Desensitizing oxaliplatin-induced fever: a case report.

Madrigal-Burgaleta R, Berges-Gimeno MP, Angel-Pereira D, Guillen-Ponce C, Sanz ML, Alvarez-Cuesta E.

J Investig Allergol Clin Immunol. 2013;23(6):435-6. No abstract available.

11.

Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.

Madrigal-Burgaleta R, Berges-Gimeno MP, Angel-Pereira D, Ferreiro-Monteagudo R, Guillen-Ponce C, Pueyo C, Gomez de Salazar E, Alvarez-Cuesta E.

Allergy. 2013 Jul;68(7):853-61. doi: 10.1111/all.12105. Epub 2013 May 6.

PMID:
23647576
12.

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

Calderon MA, Demoly P, Gerth van Wijk R, Bousquet J, Sheikh A, Frew A, Scadding G, Bachert C, Malling HJ, Valenta R, Bilo B, Nieto A, Akdis C, Just J, Vidal C, Varga EM, Alvarez-Cuesta E, Bohle B, Bufe A, Canonica WG, Cardona V, Dahl R, Didier A, Durham SR, Eng P, Fernandez-Rivas M, Jacobsen L, Jutel M, Kleine-Tebbe J, Klimek L, Lötvall J, Moreno C, Mosges R, Muraro A, Niggemann B, Pajno G, Passalacqua G, Pfaar O, Rak S, Senna G, Senti G, Valovirta E, van Hage M, Virchow JC, Wahn U, Papadopoulos N.

Clin Transl Allergy. 2012 Oct 30;2(1):20. doi: 10.1186/2045-7022-2-20.

13.

European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'.

Calderón MA, Larenas D, Kleine-Tebbe J, Jacobsen L, Passalacqua G, Eng PA, Varga EM, Valovirta E, Moreno C, Malling HJ, Alvarez-Cuesta E, Durham S, Demoly P.

Allergy. 2011 Oct;66(10):1345-59. doi: 10.1111/j.1398-9995.2011.02669.x. Epub 2011 Jun 28.

PMID:
21707645
14.

Anaphylaxis associated with the ingestion of Gold Kiwifruit.

Henríquez Santana A, González Cervera J, Carnés J, Berges Gimeno P, Alvarez Cuesta E.

Allergol Immunopathol (Madr). 2008 Nov-Dec;36(6):366-7. No abstract available.

PMID:
19150037
15.

Reply to the letter by Dr Fleming Madsen (EAACI 'Standards for practical allergen-specific immunotherapy').

Alvarez-Cuesta E, Bousquet J, Canonica WG, Durham S, Malling HJ, Passalacqua G, Valovirta E.

Allergy. 2008 Jul;63(7):939-40. doi: 10.1111/j.1398-9995.2008.01648.x. No abstract available.

PMID:
18588562
16.

Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double blind placebo controlled study.

Alvarez-Cuesta E, Berges-Gimeno P, González-Mancebo E, Fernández-Caldas E, Cuesta-Herranz J, Casanovas M.

Allergy. 2007 Jul;62(7):810-7. Erratum in: Allergy. 2007 Sep;62(9):1100. Mancebo, E G [corrected to González-Mancebo, E].

PMID:
17573730
17.

Standards for practical allergen-specific immunotherapy.

Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E; EAACI, Immunotherapy Task Force.

Allergy. 2006;61 Suppl 82:1-20. No abstract available.

PMID:
16930249
18.

Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life.

Alvarez-Cuesta E, Aragoneses-Gilsanz E, Martín-Garcia C, Berges-Gimeno P, Gonzalez-Mancebo E, Cuesta-Herranz J.

Clin Exp Allergy. 2005 May;35(5):572-8. Erratum in: Clin Exp Allergy. 2005 Nov;35(11):1504.

PMID:
15898977
19.

Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases.

Moreno C, Cuesta-Herranz J, Fernández-Távora L, Alvarez-Cuesta E; Immunotherapy Committee, Sociedad Española de Alergología e Inmunología Clínica.

Clin Exp Allergy. 2004 Apr;34(4):527-31.

PMID:
15080803
20.

The cost of asthma treatment in Spain and rationalizing the expense.

Nieto A, Alvarez-Cuesta E, Boquete M, Mazón A, de la Torre F.

J Investig Allergol Clin Immunol. 2001;11(3):139-48. Review.

PMID:
11831444

Supplemental Content

Loading ...
Support Center